Balloon Dilation Effectively Treats Sleeve Gastrectomy Stenosis
|
By HospiMedica International staff writers Posted on 30 Dec 2019 |
Endoscopic balloon dilation (EBD) appears to be a safe, minimally invasive alternative to surgical revision for sleeve gastrectomy stenosis (SGS), according to a new study.
Researchers at NYU Langone Medical Center (New York, NY, USA) and Brigham and Women's Hospital (BWH; Boston, AM, USA) conducted a systematic review and meta-analysis of studies through July 2018 that examined the influence of EBD for SGS. The primary outcome was defined as overall success rate of clinical resolution of SGS obstructive symptoms with EBD; secondary outcomes included EBD success rates for SGS in proximal or mid-distal location in early and late SGS, and success rate of cases requiring stents or salvage surgery.
In all, 18 studies encompassing 426 patients (average age 41.7, average BMI 40.1 kg/m2) from the US, France, New Zealand, Kuwait, Egypt, Brazil, Romania, Israel, and Taiwan were analyzed; the average number of dilations for all cases was 1.8 per person. Overall EBD success rate was 76%. EBD success rate for proximal SGS was 90%; for distal SGS, it was 70%. Early SGS within three months showed a 59% success rate, and late SGS (after three months) was 61%. In all, 17% of patients underwent secondary salvage surgery, with a success rate of 91%. The study was published on November 27, 2019, in Gastrointestinal Endoscopy.
“EBD should be used as first-line therapy for SGS. To minimize complications, it is important to not use large pneumatic balloons in the first several weeks following surgery. It is best to be cautious in this early time period and to use smaller hydrostatic balloons,” said senior author Christopher Thompson, MD, of BWH. “Additionally, when using pneumatic balloons, it is also important to start with the smaller 30 mm balloons and use a staged approach, never increasing balloon size in a single session.”
Stenosis following sleeve gastrectomy is a rare but potentially serious adverse event that presents with symptoms that include inability to tolerate food, nausea, vomiting, reflux symptoms, and abdominal pain. Surgical revision has so far been the treatment of choice.
Related Links:
NYU Langone Medical Center
Brigham and Women's Hospital
Researchers at NYU Langone Medical Center (New York, NY, USA) and Brigham and Women's Hospital (BWH; Boston, AM, USA) conducted a systematic review and meta-analysis of studies through July 2018 that examined the influence of EBD for SGS. The primary outcome was defined as overall success rate of clinical resolution of SGS obstructive symptoms with EBD; secondary outcomes included EBD success rates for SGS in proximal or mid-distal location in early and late SGS, and success rate of cases requiring stents or salvage surgery.
In all, 18 studies encompassing 426 patients (average age 41.7, average BMI 40.1 kg/m2) from the US, France, New Zealand, Kuwait, Egypt, Brazil, Romania, Israel, and Taiwan were analyzed; the average number of dilations for all cases was 1.8 per person. Overall EBD success rate was 76%. EBD success rate for proximal SGS was 90%; for distal SGS, it was 70%. Early SGS within three months showed a 59% success rate, and late SGS (after three months) was 61%. In all, 17% of patients underwent secondary salvage surgery, with a success rate of 91%. The study was published on November 27, 2019, in Gastrointestinal Endoscopy.
“EBD should be used as first-line therapy for SGS. To minimize complications, it is important to not use large pneumatic balloons in the first several weeks following surgery. It is best to be cautious in this early time period and to use smaller hydrostatic balloons,” said senior author Christopher Thompson, MD, of BWH. “Additionally, when using pneumatic balloons, it is also important to start with the smaller 30 mm balloons and use a staged approach, never increasing balloon size in a single session.”
Stenosis following sleeve gastrectomy is a rare but potentially serious adverse event that presents with symptoms that include inability to tolerate food, nausea, vomiting, reflux symptoms, and abdominal pain. Surgical revision has so far been the treatment of choice.
Related Links:
NYU Langone Medical Center
Brigham and Women's Hospital
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







